S Avraham

992 total citations
18 papers, 700 citations indexed

About

S Avraham is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, S Avraham has authored 18 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in S Avraham's work include Glycosylation and Glycoproteins Research (6 papers), Acne and Rosacea Treatments and Effects (3 papers) and Peptidase Inhibition and Analysis (3 papers). S Avraham is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Acne and Rosacea Treatments and Effects (3 papers) and Peptidase Inhibition and Analysis (3 papers). S Avraham collaborates with scholars based in United States and Canada. S Avraham's co-authors include Richard L Stevens, K. Frank Austen, Hava Avraham, Jian Li, Miriam Gärtner, John H. Weis, N. P. Ghildyal, Michael F. Gurish, K. Frank Austen and G.A.P. Bruns and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

S Avraham

18 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Avraham United States 13 370 230 228 218 91 18 700
Michael Loubtchenkov Finland 7 558 1.5× 155 0.7× 172 0.8× 74 0.3× 102 1.1× 9 850
Fiona McLaughlin United Kingdom 12 440 1.2× 96 0.4× 122 0.5× 49 0.2× 94 1.0× 19 653
Vanessa Ott United States 13 342 0.9× 237 1.0× 498 2.2× 287 1.3× 155 1.7× 17 1.1k
Benjamin L. Holley United States 7 246 0.7× 148 0.6× 60 0.3× 279 1.3× 66 0.7× 7 537
Gwendolyn M. Mahon United States 16 408 1.1× 195 0.8× 135 0.6× 45 0.2× 91 1.0× 21 786
Aiko Kitahara Japan 12 353 1.0× 354 1.5× 82 0.4× 44 0.2× 40 0.4× 18 604
Chantal Melchior Luxembourg 16 327 0.9× 205 0.9× 141 0.6× 374 1.7× 54 0.6× 21 719
Sandrine Guérin France 11 466 1.3× 70 0.3× 257 1.1× 43 0.2× 185 2.0× 16 816
Silvia Naus United Kingdom 10 307 0.8× 53 0.2× 243 1.1× 216 1.0× 244 2.7× 11 757
Jennifer M. Lu-Kuo United States 9 259 0.7× 78 0.3× 275 1.2× 60 0.3× 37 0.4× 9 516

Countries citing papers authored by S Avraham

Since Specialization
Citations

This map shows the geographic impact of S Avraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Avraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Avraham more than expected).

Fields of papers citing papers by S Avraham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Avraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Avraham. The network helps show where S Avraham may publish in the future.

Co-authorship network of co-authors of S Avraham

This figure shows the co-authorship network connecting the top 25 collaborators of S Avraham. A scholar is included among the top collaborators of S Avraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Avraham. S Avraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Avraham, S, et al.. (2024). A Review of Intense Pulsed Light in the Treatment of Ocular Rosacea. Journal of Cutaneous Medicine and Surgery. 28(4). 370–374. 1 indexed citations
2.
Avraham, S, et al.. (2024). Treatment of ocular rosacea: a systematic review. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(2). 167–174. 5 indexed citations
3.
Avraham, S, et al.. (2023). Treatment of pediatric ocular rosacea: A systematic review. Annales de Dermatologie et de Vénéréologie. 150(3). 199–201. 4 indexed citations
4.
Avraham, Hava, Shih Sheng Jiang, Yue Fu, et al.. (2014). Impaired neurogenesis by HIV‐1‐Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme. British Journal of Pharmacology. 172(19). 4603–4614. 23 indexed citations
5.
Seng, Seyha, Hava Avraham, Gabriel Birrane, et al.. (2008). NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors. Oncogene. 28(3). 378–389. 19 indexed citations
6.
Jiang, Shaotong, Hava Avraham, Tae‐Wan Kim, Roy S. Rogers, & S Avraham. (2006). Receptor-type PTP-NP inhibition of Dynamin-1 GTPase activity is associated with neuronal depolarization. Cellular Signalling. 18(9). 1439–1446. 5 indexed citations
7.
Koziak, Katarzyna, Elżbieta Kaczmarek, Shin‐Young Park, et al.. (2001). RAFTK/Pyk2 involvement in platelet activation is mediated by phosphoinositide 3‐kinase. British Journal of Haematology. 114(1). 134–140. 24 indexed citations
8.
Ganju, Ramesh K., William C. Hatch, T. Zheng, et al.. (1997). Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells.. Journal of Clinical Investigation. 99(7). 1798–1804. 66 indexed citations
10.
Hauser, Charlotte A. E., S Avraham, & Hava Avraham. (1993). ASSOCIATION OF RHO PROTEINS WITH THE MITOCHONDRIA ORGANELLE. International Journal of Oncology. 3(6). 1103–10. 1 indexed citations
11.
Avraham, S, Hava Avraham, K. Frank Austen, & Richard L Stevens. (1992). Negative and positive cis-acting elements in the promoter of the mouse gene that encodes the serine/glycine-rich peptide core of secretory granule proteoglycans.. Journal of Biological Chemistry. 267(1). 610–617. 19 indexed citations
12.
Gurish, Michael F., N. P. Ghildyal, K. Frank Austen, et al.. (1991). Cytokine mRNA are preferentially increased relative to secretory granule protein mRNA in mouse bone marrow-derived mast cells that have undergone IgE-mediated activation and degranulation. The Journal of Immunology. 146(5). 1527–1533. 81 indexed citations
15.
Avraham, S, et al.. (1989). Molecular cloning of a cDNA that encodes the peptide core of a mouse mast cell secretory granule proteoglycan and comparison with the analogous rat and human cDNA.. Proceedings of the National Academy of Sciences. 86(10). 3763–3767. 47 indexed citations
16.
Avraham, S, Richard L Stevens, Miriam Gärtner, et al.. (1988). Isolation of a cDNA that encodes the peptide core of the secretory granule proteoglycan of rat basophilic leukemia-1 cells and assessment of its homology to the human analogue.. Journal of Biological Chemistry. 263(15). 7292–7296. 39 indexed citations
17.
Rothenberg, Marc E., Joel L. Pomerantz, W F Owen, et al.. (1988). Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor.. Journal of Biological Chemistry. 263(27). 13901–13908. 78 indexed citations
18.
Stevens, Richard L, S Avraham, Miriam Gärtner, et al.. (1988). Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells.. Journal of Biological Chemistry. 263(15). 7287–7291. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026